17-75239458-C-T
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_138619.4(GGA3):c.1697G>A(p.Ser566Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000021 in 1,429,138 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_138619.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 31
GnomAD3 exomes AF: 0.00000467 AC: 1AN: 214162Hom.: 0 AF XY: 0.00000852 AC XY: 1AN XY: 117312
GnomAD4 exome AF: 0.00000210 AC: 3AN: 1429138Hom.: 0 Cov.: 32 AF XY: 0.00000422 AC XY: 3AN XY: 710850
GnomAD4 genome Cov.: 31
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.1697G>A (p.S566N) alteration is located in exon 14 (coding exon 14) of the GGA3 gene. This alteration results from a G to A substitution at nucleotide position 1697, causing the serine (S) at amino acid position 566 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at